BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 34848336)

  • 1. Synaptic pathology in Huntington's disease: Beyond the corticostriatal pathway.
    Barry J; Bui MTN; Levine MS; Cepeda C
    Neurobiol Dis; 2022 Jan; 162():105574. PubMed ID: 34848336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced striatopallidal gamma-aminobutyric acid (GABA)
    Perez-Rosello T; Gelman S; Tombaugh G; Cachope R; Beaumont V; Surmeier DJ
    Mov Disord; 2019 May; 34(5):684-696. PubMed ID: 30726572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.
    Cepeda C; Levine MS
    Neuroscientist; 2022 Feb; 28(1):20-40. PubMed ID: 33198566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms.
    Farrar AM; Callahan JW; Abercrombie ED
    Exp Neurol; 2011 Dec; 232(2):119-25. PubMed ID: 21864528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal Mutant Huntingtin Protein Levels Decline with Age in Homozygous Huntington's Disease Knock-In Mouse Models.
    Franich NR; Basso M; André EA; Ochaba J; Kumar A; Thein S; Fote G; Kachemov M; Lau AL; Yeung SY; Osmand A; Zeitlin SO; Ratan RR; Thompson LM; Steffan JS
    J Huntingtons Dis; 2018; 7(2):137-150. PubMed ID: 29843246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Huntington's disease: cellular and molecular basis of pathology].
    Korzhova VV; Artamonov DN; Vlasova OL; Bezprozvannyĭ IB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2014; 64(4):359-75. PubMed ID: 25723022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation.
    Rangel-Barajas C; Rebec GV
    J Huntingtons Dis; 2016 Dec; 5(4):303-331. PubMed ID: 27983564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired development of cortico-striatal synaptic connectivity in a cell culture model of Huntington's disease.
    Buren C; Parsons MP; Smith-Dijak A; Raymond LA
    Neurobiol Dis; 2016 Mar; 87():80-90. PubMed ID: 26711622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the htt
    McAdam RL; Morton A; Gordon SL; Alterman JF; Khvorova A; Cousin MA; Smillie KJ
    Neurobiol Dis; 2020 Feb; 134():104637. PubMed ID: 31614197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic deficits selectively boost cortical intratelencephalic control of striatum in male Huntington's disease model mice.
    Pancani T; Day M; Tkatch T; Wokosin DL; González-Rodríguez P; Kondapalli J; Xie Z; Chen Y; Beaumont V; Surmeier DJ
    Nat Commun; 2023 Mar; 14(1):1398. PubMed ID: 36914640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
    Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
    J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interactions within striatal microcircuit in animal models of Huntington's disease.
    Ghiglieri V; Bagetta V; Calabresi P; Picconi B
    Neuroscience; 2012 Jun; 211():165-84. PubMed ID: 21756979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
    Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
    Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass Spectrometry Analysis of Wild-Type and Knock-in Q140/Q140 Huntington's Disease Mouse Brains Reveals Changes in Glycerophospholipids Including Alterations in Phosphatidic Acid and Lyso-Phosphatidic Acid.
    Vodicka P; Mo S; Tousley A; Green KM; Sapp E; Iuliano M; Sadri-Vakili G; Shaffer SA; Aronin N; DiFiglia M; Kegel-Gleason KB
    J Huntingtons Dis; 2015; 4(2):187-201. PubMed ID: 26397899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease.
    Kacher R; Lamazière A; Heck N; Kappes V; Mounier C; Despres G; Dembitskaya Y; Perrin E; Christaller W; Sasidharan Nair S; Messent V; Cartier N; Vanhoutte P; Venance L; Saudou F; Néri C; Caboche J; Betuing S
    Brain; 2019 Aug; 142(8):2432-2450. PubMed ID: 31286142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble mutant huntingtin drives early human pathogenesis in Huntington's disease.
    Miguez A; Gomis C; Vila C; Monguió-Tortajada M; Fernández-García S; Bombau G; Galofré M; García-Bravo M; Sanders P; Fernández-Medina H; Poquet B; Salado-Manzano C; Roura S; Alberch J; Segovia JC; Allen ND; Borràs FE; Canals JM
    Cell Mol Life Sci; 2023 Aug; 80(8):238. PubMed ID: 37535170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain urea increase is an early Huntington's disease pathogenic event observed in a prodromal transgenic sheep model and HD cases.
    Handley RR; Reid SJ; Brauning R; Maclean P; Mears ER; Fourie I; Patassini S; Cooper GJS; Rudiger SR; McLaughlan CJ; Verma PJ; Gusella JF; MacDonald ME; Waldvogel HJ; Bawden CS; Faull RLM; Snell RG
    Proc Natl Acad Sci U S A; 2017 Dec; 114(52):E11293-E11302. PubMed ID: 29229845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease.
    Ferrante A; Martire A; Pepponi R; Varani K; Vincenzi F; Ferraro L; Beggiato S; Tebano MT; Popoli P
    Neurobiol Dis; 2014 Nov; 71():193-204. PubMed ID: 25132555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Replenishment of Cortico-Striatal Synaptic Glutamate in Huntington's Disease Mouse Model.
    Buren C; Tu G; Raymond LA
    J Huntingtons Dis; 2020; 9(2):149-161. PubMed ID: 32310183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.